Variant report
Variant | esv14111 |
---|---|
Chromosome Location | chr6:29203155-29224097 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr6:29190205..29192044-chr6:29201799..29204663,2 | K562 | blood: |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-OR2J2-3 | chr6:29204413-29204664 | NONHSAT108517 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000232505 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs185030752 | chr6:29203160-29203161 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs112198027 | chr6:29203171-29203172 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs545245948 | chr6:29203238-29203239 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs116741238 | chr6:29203250-29203251 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs530727161 | chr6:29203318-29203319 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs200880483 | chr6:29203374-29203375 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs3117344 | chr6:29203407-29203408 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs563428621 | chr6:29203443-29203444 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs529279997 | chr6:29203456-29203457 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs370410952 | chr6:29203479-29203480 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs548987269 | chr6:29203487-29203488 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs138124265 | chr6:29203583-29203584 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs528792405 | chr6:29203610-29203611 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs116432329 | chr6:29203662-29203663 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs571787426 | chr6:29203728-29203729 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs537625074 | chr6:29203756-29203757 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs557120303 | chr6:29203814-29203815 | Enhancers Weak transcription Bivalent Enhancer | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs567390030 | chr6:29203852-29203853 | Enhancers Weak transcription Bivalent Enhancer | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs536315465 | chr6:29203854-29203855 | Enhancers Weak transcription Bivalent Enhancer | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs144123695 | chr6:29203880-29203881 | Enhancers Weak transcription Bivalent Enhancer | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs56195318 | chr6:29203893-29203894 | Enhancers Weak transcription Bivalent Enhancer | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs149134362 | chr6:29203900-29203901 | Enhancers Weak transcription Bivalent Enhancer | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs371682750 | chr6:29203908-29203909 | Enhancers Weak transcription Bivalent Enhancer | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs3130816 | chr6:29203911-29203912 | Enhancers Weak transcription Bivalent Enhancer | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
25 | rs111657818 | chr6:29203939-29203940 | Enhancers Weak transcription Bivalent Enhancer | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs191009859 | chr6:29203946-29203947 | Enhancers Weak transcription Bivalent Enhancer | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs558807415 | chr6:29203960-29203961 | Enhancers Weak transcription Bivalent Enhancer | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs183102421 | chr6:29203996-29203997 | Enhancers Weak transcription Bivalent Enhancer | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs115203555 | chr6:29204027-29204028 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs187400205 | chr6:29204106-29204107 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs529363522 | chr6:29204113-29204114 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs542672210 | chr6:29204161-29204162 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs565533446 | chr6:29204390-29204391 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs146422335 | chr6:29204446-29204447 | Weak transcription Enhancers | Chromatin interactive regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs529962373 | chr6:29204448-29204449 | Weak transcription Enhancers | Chromatin interactive regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs528484793 | chr6:29204461-29204462 | Weak transcription Enhancers | Chromatin interactive regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs551820251 | chr6:29204466-29204467 | Weak transcription Enhancers | Chromatin interactive regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs571886705 | chr6:29204476-29204477 | Weak transcription Enhancers | Chromatin interactive regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs140021272 | chr6:29204581-29204582 | Weak transcription Enhancers | Chromatin interactive regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs191629774 | chr6:29204582-29204583 | Weak transcription Enhancers | Chromatin interactive regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs114111808 | chr6:29204641-29204642 | Weak transcription Enhancers | Chromatin interactive regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs548062364 | chr6:29204666-29204667 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs528841439 | chr6:29204667-29204668 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs76355441 | chr6:29204772-29204773 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs112674084 | chr6:29204776-29204777 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs116570142 | chr6:29204926-29204927 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs183418362 | chr6:29205013-29205014 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs558607369 | chr6:29205068-29205069 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs55698774 | chr6:29205077-29205078 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs544067674 | chr6:29205129-29205130 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Leukemia | 21518781 | CNVD |
Cancer | 21637783 | CNVD |
Facial dysmorphism | 22105932 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Bladder cancer | 19088036 | CNVD |
Wilms tumour | 21544195 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Biliary cancer | 19435499 | CNVD |
Malaria | 21533027 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
Lung cancer | 18438408 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Gastric cancer | 16891809 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Autism | 21448237 | CNVD |
Cancer | 20164919 | CNVD |
Melanoma | 18172304 | CNVD |
Breast cancer | 22844521 | CNVD |
HIV/AIDS | 22844521 | CNVD |
Ovarian cancer | 22844521 | CNVD |
Prostate cancer | 22844521 | CNVD |
Psoriasis | 22844521 | CNVD |
Rheumatoid arthritis | 22844521 | CNVD |
Sclerosis systemic | 22844521 | CNVD |
Systemic lupus erythematosus | 22844521 | CNVD |
Breast cancer | 22522925 | CNVD |
Breast cancer | 21552322 | CNVD |
Immune disease | 21076436 | CNVD |
Autoimmune disease | 19135723 | CNVD |
Systemic lupus erythematosus | 17953491 | CNVD |
Recurrent Infections | 22737222 | CNVD |
Systemic lupus erythematosus | 21904924 | CNVD |
Ependymoma | 19289631 | CNVD |
Gestational infection | 22844521 | CNVD |
Head circumference | 22844521 | CNVD |
Infertility | 22844521 | CNVD |
Recurrent birth weight diabetes | 22844521 | CNVD |
Obesity | 22844521 | CNVD |
Recurrent pregnancy loss | 22844521 | CNVD |
Intellectual disability | 21811512 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Nasopharyngeal cancer | 22815911 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 17133270 | CNVD |
Autism | 22495311 | CNVD |
Cancer | 16790693 | CNVD |
Breast cancer | 22032731 | CNVD |
Cervical cancer | 21062161 | CNVD |
Breast cancer | 21785460 | CNVD |
Retinoblastoma | 16790693 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Cancer | 21183584 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Gastric cancer | 17908304 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 16397240 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 21364760 | CNVD |
Schizophrenia | 19571809 | CNVD |
Schizophrenia | 19571808 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Neuroblastoma | 16790693 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
abnormal development | 18461090 | CNVD |
Breast cancer | 21509527 | CNVD |
Schizophrenia | 23813976 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:29185800-29212000 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
2 | chr6:29199200-29203600 | Weak transcription | iPS-20b Cell Line | embryonic stem cell |
3 | chr6:29202600-29205000 | Enhancers | HUES64 Cell Line | embryonic stem cell |
4 | chr6:29203000-29203200 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
5 | chr6:29203000-29204200 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
6 | chr6:29203000-29204400 | Enhancers | H1 Cell Line | embryonic stem cell |
7 | chr6:29203000-29204800 | Enhancers | HUES48 Cell Line | embryonic stem cell |
8 | chr6:29203000-29205000 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
9 | chr6:29203200-29204200 | Enhancers | HUES6 Cell Line | embryonic stem cell |
10 | chr6:29203200-29205000 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
11 | chr6:29203600-29205000 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
12 | chr6:29203800-29204000 | Bivalent Enhancer | GM12878-XiMat | blood |
13 | chr6:29203800-29204200 | Enhancers | H9 Cell Line | embryonic stem cell |
14 | chr6:29204400-29205000 | Weak transcription | H1 Cell Line | embryonic stem cell |
15 | chr6:29205000-29205200 | Enhancers | H1 Cell Line | embryonic stem cell |
16 | chr6:29211000-29211400 | ZNF genes & repeats | Liver | Liver |
17 | chr6:29212000-29212200 | ZNF genes & repeats | iPS DF 19.11 Cell Line | embryonic stem cell |
18 | chr6:29215600-29215800 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
19 | chr6:29215800-29219600 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
20 | chr6:29218400-29219800 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
21 | chr6:29219600-29219800 | ZNF genes & repeats | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |